Shanghai New Asiatic Pharmaceuticals

Shanghai New Asiatic Pharmaceuticals is a Shanghai-based pharmaceutical manufacturer focused primarily on anti-infective medicines. The company is a subsidiary of Shanghai Pharmaceuticals and was formed through the strategic integration of legacy antibiotic manufacturers including Xinya, Xianfeng, and No. 4 Pharmaceutical. Its business spans research, active pharmaceutical ingredients, finished dosage formulations, manufacturing, and sales, with established brands and commercial products such as ceftriaxone, cefotaxime, cefoperazone, cefotiam, and cefazolin. The company appears to be a mature commercial pharma business rather than an innovation-stage biotech, with strengths in antibiotics and related anti-infective supply chains.